Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: PATHOVACS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-20 to 2023-09-19
Current total value of award: $393833
Description: PATHOVACS, INC. WILL DEVELOP A PROTOTYPE IN VITRO DIAGNOSTIC DEVICE FOR QUALITATIVE SCREENING OF INDIVIDUALS FOR ANTI-HEPATITIS C VIRUS (HCV) ANTIBODIES TO DETERMINE HCV EXPOSURE.